We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+7.4%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$471B
AUM Growth
+$12.9B
Cap. Flow
-$11.2B
Cap. Flow %
-2.38%
Top 10 Hldgs %
12.86%
Holding
2,627
New
87
Increased
929
Reduced
999
Closed
89

Top Sells

Rank Stock Value
1
RTX icon
RTX Corp
RTX
+$1.73B
2
ECL icon
Ecolab
ECL
+$1.17B
3
CCI icon
Crown Castle
CCI
+$906M
4
PSX icon
Phillips 66
PSX
+$775M
5
GILD icon
Gilead Sciences
GILD
+$756M

Sector Composition

Rank Sector Weight
1 Healthcare 19.84%
2 Consumer Discretionary 13.93%
3 Financials 13.41%
4 Industrials 12.4%
5 Technology 9.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WAL icon
426
Western Alliance Bancorporation
WAL
$9.01B
$205M 0.04%
7,370,517
+41,270
+0.6% +$1.06M
VEEV icon
427
Veeva Systems
VEEV
$39.2B
$204M 0.04%
7,721,190
-232,260
-3% -$6.53M
THOR
428
DELISTED
THORATEC CORPORATION
THOR
$201M 0.04%
6,183,367
+644,664
+12% +$18.8M
ACAD icon
429
Acadia Pharmaceuticals
ACAD
$5.07B
$198M 0.04%
6,240,798
-292,545
-4% -$8.3M
DISCK
430
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
$198M 0.04%
5,870,105
-7,434,637
-56% -$253M
MSA icon
431
Mine Safety
MSA
$7.41B
$197M 0.04%
3,707,239
-240,568
-6% -$12.7M
LRCX icon
432
Lam Research
LRCX
$408B
$196M 0.04%
24,766,460
-9,954,270
-29% -$77.2M
RTN
433
DELISTED
Raytheon Company
RTN
$195M 0.04%
1,805,103
-23,780
-1% -$2.45M
CAT icon
434
Caterpillar
CAT
$393B
$195M 0.04%
2,128,939
+505,863
+31% +$49.2M
WCN
435
Waste Connections
WCN
$41.6B
$195M 0.04%
6,643,854
+356,737
+6% +$11.2M
RF icon
436
Regions Financial
RF
$26.9B
$195M 0.04%
18,440,005
+103,380
+0.6% +$1.03M
PRA
437
DELISTED
ProAssurance
PRA
$194M 0.04%
4,303,634
+1,646
+0% +$75.3K
AAN.A
438
DELISTED
The Aaron's Company Inc Class A
AAN.A
$194M 0.04%
6,353,474
-65,100
-1% -$1.99M
BSMX
439
DELISTED
Banco Santander México, S, A., Institución de Banca Múltiple, Grupo Financiero Santander México
BSMX
$193M 0.04%
18,676,289
+1,364,310
+8% +$16M
MCHP icon
440
Microchip Technology
MCHP
$43.1B
$192M 0.04%
8,495,948
+93,444
+1% +$2.03M
KKD
441
DELISTED
KRISPY KREME DOUGHNUTS INC
KKD
$191M 0.04%
9,676,864
+55,710
+0.6% +$1.06M
MIK
442
DELISTED
Michaels Stores, Inc
MIK
$191M 0.04%
7,710,260
+5,467
+0.1% +$113K
EPC icon
443
Edgewell Personal Care
EPC
$1.32B
$188M 0.04%
1,977,321
+166,484
+9% +$15.3M
SWX icon
444
Southwest Gas
SWX
$6.68B
$188M 0.04%
3,044,100
+8,580
+0.3% +$487K
HOMB icon
445
Home BancShares
HOMB
$6.23B
$188M 0.04%
11,690,966
+2,260,250
+24% +$35M
AWAY
446
DELISTED
HOMEAWAY INC COM
AWAY
$187M 0.04%
6,264,198
-3,015,002
-32% -$95.1M
DEI icon
447
Douglas Emmett
DEI
$1.95B
$186M 0.04%
6,547,380
+9,145
+0.1% +$252K
TRIP icon
448
TripAdvisor
TRIP
$1.26B
$185M 0.04%
2,476,499
+553,332
+29% +$43.2M
PSX icon
449
Phillips 66
PSX
$90B
$185M 0.04%
2,573,223
-10,505,223
-80% -$775M
MTD icon
450
Mettler-Toledo International
MTD
$28.8B
$183M 0.04%
606,384
+835
+0.1% +$230K

Similar funds

T. Rowe Price Associates's Q4 2014 Portfolio in Review

As of Q4 2014, T. Rowe Price Associates held 2,627 positions worth $471B, up 2.8% from $458B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

T. Rowe Price Associates's Q4 2014 filing shows 87 new, 929 increased, 999 reduced and 89 closed positions. Its largest new stake was Keysight: 17,553,953 shares worth $593M. The largest sale was RTX Corp, an estimated $1.73B.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Financials.

  • T. Rowe Price Associates's largest Q4 2014 buy was Keysight: 17,553,953 shares worth $593M.
  • T. Rowe Price Associates added most to Allergan plc in Q4 2014, an estimated $1.66B increase.
  • T. Rowe Price Associates's biggest Q4 2014 reduction was RTX Corp, cutting an estimated $1.73B.
  • T. Rowe Price Associates fully exited ATHLON ENERGY INC COM in Q4 2014, selling an estimated $499M.
  • T. Rowe Price Associates's ten largest holdings make up 13% of its $471B portfolio in Q4 2014.
  • T. Rowe Price Associates opened 87 new positions and closed 89 in Q4 2014.
  • T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $471B.

Based on T. Rowe Price Associates's 13F filing for Q4 2014, filed 13 Feb 2015.